Millennium Management
BIOA

Millennium Management’s BioAge Labs BIOA Stock Holding History

Millennium Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.53M Buy
430,463
+202,049
+88% +$3.89M ﹤0.01% 2473
2025
Q4 		$3.02M Sell
228,414
-78,138
-25% -$693K ﹤0.01% 3547
2025
Q3 		$1.8M Buy
306,552
+270,479
+750% +$1.27M ﹤0.01% 4155
2025
Q2 		$149K Buy
+36,073
New +$145K ﹤0.01% 5446
2025
Q1 		– Sell
-14,965
Closed -$86.6K – 6513
2024
Q4 		$86.6K Sell
14,965
-151,057
-91% -$2.6M ﹤0.01% 5497
2024
Q3 		$3.45M Buy
+166,022
New +$3.33M ﹤0.01% 3179

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management's BIOA Position: Q1 2026 in Review

Millennium Management increased its BioAge Labs (BIOA) stake by 88% in Q1 2026, buying an estimated $3.89M and bringing the position to 430,463 shares worth $7.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Millennium Management first reported a position in BIOA in Q3 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Millennium Management held 430,463 shares of BioAge Labs worth $7.53M as of Q1 2026.
  • Millennium Management bought 202,049 BioAge Labs shares in Q1 2026, an estimated $3.89M.
  • BioAge Labs made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2473 holding.
  • Millennium Management first reported a position in BioAge Labs in Q3 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.